A pilot study of zoledronic acid in the treatment of patients with advanced malignant pleural mesothelioma
{{output}}
Purpose: Malignant pleural mesothelioma (MPM) is a rare malignancy with a dismal median survival of <12 months with current therapy. Single and combination chemotherapy regimens have shown only modest clinical benefit. In preclin... ...
